Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04855240 · ClinicalTrials.gov registry record · Phase 2
Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy
A Phase 2 study, sponsored by ACADIA Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 239
- Enrollment target
NCT04855240 is a Phase 2 study that has completed, run by ACADIA Pharmaceuticals. The registered enrollment target is 239 participants.
The verdict
NCT04855240, a Phase 2 study, has completed, sponsored by ACADIA Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 239 participants
- Enrollment target
Study Summary
To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain
Interventions
- DRUG Placebo
- DRUG ACP-044 Dose A
- DRUG ACP-044 Dose B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2021-03-29 |
| Est. Completion | 2022-03-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04855240
The ClinicalTrials.gov registry entry for NCT04855240 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ACADIA Pharmaceuticals, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04855240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04855240 about?
NCT04855240 is a clinical study titled "Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy". To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain
What is the current status of trial NCT04855240?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 239 participants. The study started on 2021-03-29. Estimated completion is 2022-03-14.
What interventions are being tested in trial NCT04855240?
The interventions under investigation include: Placebo (DRUG), ACP-044 Dose A (DRUG), ACP-044 Dose B (DRUG).
Who is sponsoring clinical trial NCT04855240?
This trial is sponsored by ACADIA Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.